Delcher Anne, Hily Sylvie, Boureau Anne Sophie, Chapelet Guillaume, Berrut Gilles, de Decker Laure
Department of Geriatrics, Saint-Nazaire Hospital, Saint-Nazaire, France.
Department of Geriatrics, Nantes University Hospital, Nantes, France.
PLoS One. 2015 Nov 4;10(11):e0141779. doi: 10.1371/journal.pone.0141779. eCollection 2015.
To determine whether there is an association between overprescription of proton pump inhibitors (PPIs) and multimorbidities in older patients.
Multicenter prospective study.
Acute geriatric medicine at the University Hospital of Nantes and the Hospital of Saint-Nazaire.
Older patients aged 75 and over hospitalized in acute geriatric medicine.
Older patients in acute geriatric medicine who received proton pump inhibitors. Variables studied were individual multimorbidities, the burden of multimorbidity evaluated by the Cumulative Illness Rating Scale, age, sex, type of residence (living in nursing home or not), functional abilities (Lawton and Katz scales), nutritional status (Body Mass Index), and the type of concomitant medications (antiaggregant, corticosteroids', or anticoagulants).
Overprescription of proton pump inhibitors was found in 73.9% older patients. In the full model, cardiac diseases (odds ratio [OR] = 4.17, p = 0.010), metabolic diseases (OR = 2.14, p = 0.042) and corticosteroids (OR = 5.39, p = 0.028) were significantly associated with overprescription of proton pump inhibitors. Esogastric diseases (OR = 0.49, p = 0.033) were negatively associated with overprescription of proton pump inhibitors.
Cardiac diseases and metabolic diseases were significantly associated with overprescription of proton pump inhibitors.
确定老年患者质子泵抑制剂(PPI)过度处方与多种疾病并存之间是否存在关联。
多中心前瞻性研究。
南特大学医院和圣纳泽尔医院的急性老年医学科。
75岁及以上因急性老年医学疾病住院的老年患者。
接受质子泵抑制剂治疗的急性老年医学科老年患者。研究的变量包括个体多种疾病、用累积疾病评分量表评估的多种疾病负担、年龄、性别、居住类型(是否住在养老院)、功能能力(Lawton和Katz量表)、营养状况(体重指数)以及伴随用药类型(抗血小板药、皮质类固醇或抗凝剂)。
73.9%的老年患者存在质子泵抑制剂过度处方情况。在完整模型中,心脏病(比值比[OR]=4.17,p=0.010)、代谢性疾病(OR=2.14,p=0.042)和皮质类固醇(OR=5.39,p=0.028)与质子泵抑制剂过度处方显著相关。食管胃部疾病(OR=0.49,p=0.033)与质子泵抑制剂过度处方呈负相关。
心脏病和代谢性疾病与质子泵抑制剂过度处方显著相关。